AI Insight
Researchers have identified an enzyme called UBE2N that appears to protect against the progression of fatty liver disease, a condition affecting approximately 100 million Americans. The enzyme functions by helping liver cells remove damaged mitochondria and metabolize fat, which may prevent the development of MASH (metabolic dysfunction-associated steatohepatitis), a more severe form of the disease characterized by inflammation, scarring, and cellular damage.
Why it matters
This discovery could lead to new therapeutic approaches for preventing fatty liver disease from progressing to more dangerous stages. Given the widespread prevalence of fatty liver disease in the United States, treatments targeting this enzyme pathway could have significant public health impact.
Understand the Science
Scientists have identified an enzyme that may act as a natural defense against the worsening of fatty liver disease, which affects an estimated 100 million Americans. The enzyme, called UBE2N, helps liver cells clear away damaged mitochondria and break down fat, potentially preventing the inflammation, scarring, and cell damage associated with the more dangerous condition MASH.
Source: This protective enzyme could help stop fatty liver disease from getting worse